- Home
- AXSM vs BCPC Comparison
AXSM vs BCPC Comparison
Compare AXSM & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BCPC
- Stock Information
- Founded
- AXSM 2012
- BCPC 1967
- Country
- AXSM United States
- BCPC United States
- Employees
- AXSM N/A
- BCPC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BCPC Major Chemicals
- Sector
- AXSM Health Care
- BCPC Industrials
- Exchange
- AXSM Nasdaq
- BCPC Nasdaq
- Market Cap
- AXSM 5.1B
- BCPC 5.2B
- IPO Year
- AXSM 2015
- BCPC N/A
- Fundamental
- Price
- AXSM $110.12
- BCPC $157.50
- Analyst Decision
- AXSM Strong Buy
- BCPC Strong Buy
- Analyst Count
- AXSM 17
- BCPC 1
- Target Price
- AXSM $171.65
- BCPC $180.00
- AVG Volume (30 Days)
- AXSM 672.7K
- BCPC 161.5K
- Earning Date
- AXSM 08-04-2025
- BCPC 07-25-2025
- Dividend Yield
- AXSM N/A
- BCPC 0.55%
- EPS Growth
- AXSM N/A
- BCPC 17.80
- EPS
- AXSM N/A
- BCPC 4.17
- Revenue
- AXSM $432,157,000.00
- BCPC $964,544,000.00
- Revenue This Year
- AXSM $62.57
- BCPC $8.74
- Revenue Next Year
- AXSM $59.96
- BCPC $6.85
- P/E Ratio
- AXSM N/A
- BCPC $37.92
- Revenue Growth
- AXSM 72.16
- BCPC 3.76
- 52 Week Low
- AXSM $72.21
- BCPC $145.70
- 52 Week High
- AXSM $139.13
- BCPC $186.03
- Technical
- Relative Strength Index (RSI)
- AXSM 56.52
- BCPC 39.32
- Support Level
- AXSM $108.48
- BCPC $158.14
- Resistance Level
- AXSM $114.66
- BCPC $164.01
- Average True Range (ATR)
- AXSM 3.47
- BCPC 2.74
- MACD
- AXSM 0.87
- BCPC -0.19
- Stochastic Oscillator
- AXSM 64.95
- BCPC 5.69
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.